These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 23176753)
1. Cyclic analogs of galanin and neuropeptide Y by hydrocarbon stapling. Green BR; Klein BD; Lee HK; Smith MD; Steve White H; Bulaj G Bioorg Med Chem; 2013 Jan; 21(1):303-10. PubMed ID: 23176753 [TBL] [Abstract][Full Text] [Related]
2. Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics. Zhang L; Klein BD; Metcalf CS; Smith MD; McDougle DR; Lee HK; White HS; Bulaj G Mol Pharm; 2013 Feb; 10(2):574-85. PubMed ID: 23259957 [TBL] [Abstract][Full Text] [Related]
3. Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities. Green BR; White KL; McDougle DR; Zhang L; Klein B; Scholl EA; Pruess TH; White HS; Bulaj G J Pept Sci; 2010 Sep; 16(9):486-95. PubMed ID: 20645434 [TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant neuropeptides as drug leads for neurological diseases. Robertson CR; Flynn SP; White HS; Bulaj G Nat Prod Rep; 2011 Apr; 28(4):741-62. PubMed ID: 21340067 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. Bulaj G; Green BR; Lee HK; Robertson CR; White K; Zhang L; Sochanska M; Flynn SP; Scholl EA; Pruess TH; Smith MD; White HS J Med Chem; 2008 Dec; 51(24):8038-47. PubMed ID: 19053761 [TBL] [Abstract][Full Text] [Related]
6. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855 [TBL] [Abstract][Full Text] [Related]
7. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Berglund MM; Saar K; Lundell I; Langel U; Larhammar D Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204 [TBL] [Abstract][Full Text] [Related]
8. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype. Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563 [TBL] [Abstract][Full Text] [Related]
9. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069 [TBL] [Abstract][Full Text] [Related]
10. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors. Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568 [TBL] [Abstract][Full Text] [Related]
11. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Weinshenker D Epilepsia; 2008 Nov; 49 Suppl 8():104-7. PubMed ID: 19049603 [TBL] [Abstract][Full Text] [Related]
12. [The neuropeptide galanin and the seizure reactions of the developing brain]. Chepurnov SA; Chepurnova NE; Abbasova KR; Smirnova MP Usp Fiziol Nauk; 1997; 28(2):3-20. PubMed ID: 9235805 [TBL] [Abstract][Full Text] [Related]
13. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment. Doughty MB; Hu L Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Beck-Sickinger AG; Jung G Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y. Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906 [TBL] [Abstract][Full Text] [Related]
17. The ketogenic diet does not alter brain expression of orexigenic neuropeptides. Tabb K; Szot P; White SS; Liles LC; Weinshenker D Epilepsy Res; 2004 Nov; 62(1):35-9. PubMed ID: 15519130 [TBL] [Abstract][Full Text] [Related]
18. Interaction between neuropeptide Y immunoreactive neurons and galanin immunoreactive neurons in the brain of the masu salmon, Oncorhynchus masou. Amano M; Amiya N; Hiramatsu M; Tomioka T; Oka Y Neurosci Lett; 2009 Oct; 462(1):33-8. PubMed ID: 19560521 [TBL] [Abstract][Full Text] [Related]
19. Anatomical relations between neuropeptide Y, galanin, and gonadotropin-releasing hormone in the brain of chondrostean, the Siberian sturgeon Acipenser baeri. Amiya N; Amano M; Tabuchi A; Oka Y Neurosci Lett; 2011 Oct; 503(2):87-92. PubMed ID: 21871949 [TBL] [Abstract][Full Text] [Related]